Login to Your Account

Shenogen, Lee's partner to bring drug to China's liver cancer patients

By Shannon Ellis
Staff Writer

Thursday, August 25, 2016

Beijing Shenogen Pharma Group Ltd. has signed a co-development deal with Lee's Pharmaceutical Holdings Ltd. to combine Shenogen's lead compound, icaritin, with Pexa-Vec.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription